97 related articles for article (PubMed ID: 21681744)
1. Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma.
Marion A; Dieudonné FX; Patiño-Garcia A; Lecanda F; Marie PJ; Modrowski D
Int J Cancer; 2012 Jun; 130(11):2514-25. PubMed ID: 21681744
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
4. High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.
Dieudonné FX; Marion A; Haÿ E; Marie PJ; Modrowski D
Cancer Res; 2010 Jul; 70(13):5399-408. PubMed ID: 20530678
[TBL] [Abstract][Full Text] [Related]
5. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
8. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
9. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 gene polymorphisms and risk of chemoresistant pediatric osteosarcoma.
Zhou Y; Liu B; Wang M; Ni J
Pediatr Blood Cancer; 2014 Apr; 61(4):612-7. PubMed ID: 24123836
[TBL] [Abstract][Full Text] [Related]
11. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling.
Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY
Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271
[TBL] [Abstract][Full Text] [Related]
12. TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma.
Dai H; Huang Y; Li Y; Meng G; Wang Y; Guo QN
Carcinogenesis; 2012 Jan; 33(1):30-40. PubMed ID: 22021909
[TBL] [Abstract][Full Text] [Related]
13. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.
Daqian W; Chuandong W; Xinhua Q; Songtao A; Kerong D
Chem Biol Interact; 2015 Jul; 237():25-30. PubMed ID: 25980584
[TBL] [Abstract][Full Text] [Related]
14. Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line.
Wang Z; Xia Q; Cui J; Diao Y; Li J
Oncol Rep; 2014 Jun; 31(6):2720-6. PubMed ID: 24788927
[TBL] [Abstract][Full Text] [Related]
15. Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells.
Roncuzzi L; Pancotti F; Baldini N
Oncol Rep; 2014 Jul; 32(1):389-94. PubMed ID: 24840054
[TBL] [Abstract][Full Text] [Related]
16. Identification of drug-regulated genes in osteosarcoma cells.
Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
[TBL] [Abstract][Full Text] [Related]
17. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
18. The ERK/eIF4F/Bcl-XL pathway mediates SGP-2 induced osteosarcoma cells apoptosis in vitro and in vivo.
Zhang Z; Zheng Y; Zhu R; Zhu Y; Yao W; Liu W; Gao X
Cancer Lett; 2014 Oct; 352(2):203-13. PubMed ID: 25025927
[TBL] [Abstract][Full Text] [Related]
19. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.
Eliseev RA; Schwarz EM; Zuscik MJ; O'Keefe RJ; Drissi H; Rosier RN
Exp Cell Res; 2006 Jan; 312(1):40-50. PubMed ID: 16259979
[TBL] [Abstract][Full Text] [Related]
20. Pien Tze Huang induces apoptosis in multidrug‑resistant U2OS/ADM cells via downregulation of Bcl‑2, survivin and P-gp and upregulation of Bax.
Zhang Y; Wang Q; Niu S; Liu J; Zhang L
Oncol Rep; 2014 Feb; 31(2):763-70. PubMed ID: 24337940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]